A BST RAC T Percutaneous left atrial appendage occlusion (LAAO), currently recognized as a procedure with relatively low risk, is increasingly being adopted in clinical practice. However, due to the preventive nature of the procedure and the necessity to compare it with newer and safer oral anticoagulants, further optimization is required to address remaining challenges. These latter include acquiring comprehensive data on safety and efficacy, establishing standardized pre -procedural planning, and simplifying procedural process. Consequently, we have provided an overview that encompasses future opportunities for enhancing procedural safety and efficacy, thereby establishing LAAO as the mainstream strategy for stroke and systemic embolism prevention in patients with atrial fibrillation and absolute contraindications to anticoagulant drugs. .
Future of left atrial appendage interventions / Casenghi, Matteo; Corradetti, Sara; Navarra, Emiliano; Giovannelli, Francesca; Tommasino, Antonella; Rigattieri, Stefano; Barbato, Emanuele; Berni, Andrea. - In: MINERVA CARDIOLOGY AND ANGIOLOGY. - ISSN 2724-5772. - (2024). [10.23736/S2724-5683.24.06458-5]
Future of left atrial appendage interventions
Corradetti, Sara;Barbato, Emanuele;Berni, Andrea
2024
Abstract
A BST RAC T Percutaneous left atrial appendage occlusion (LAAO), currently recognized as a procedure with relatively low risk, is increasingly being adopted in clinical practice. However, due to the preventive nature of the procedure and the necessity to compare it with newer and safer oral anticoagulants, further optimization is required to address remaining challenges. These latter include acquiring comprehensive data on safety and efficacy, establishing standardized pre -procedural planning, and simplifying procedural process. Consequently, we have provided an overview that encompasses future opportunities for enhancing procedural safety and efficacy, thereby establishing LAAO as the mainstream strategy for stroke and systemic embolism prevention in patients with atrial fibrillation and absolute contraindications to anticoagulant drugs. .File | Dimensione | Formato | |
---|---|---|---|
Casenghi_Future-left-atrial_2024.pdf
solo gestori archivio
Note: Online ahead of print
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
8.49 MB
Formato
Adobe PDF
|
8.49 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.